Fig. 7
From: A Novel Solubility-Enhanced Rubusoside-Based Micelles for Increased Cancer Therapy
The anti-cancer effects of RUB-based micelles on MCF-7 cells. a Apoptosis of MCF-7 cells treated with indicated formulations of Rh2 (2.19 mM) and SM (0.26 mM) for 24 h was analyzed by flow cytometry using Annexin V-FITC/PI staining. b Cell viability of MCF-7 cells was measured by MTT method, which was treated with indicated formulations of Rh2 (2.19 mM) and SM (0.26 mM) for 24 h. c, d Time- and dose-dependent manners of cell viability of MCF-7 cells treated with indicated formulations were measured by MTT method. c represented for Rh2 (2.19 mM). SM’s concentration was 0.26 mM. e In vitro release profile of Rh2 and SM from RUB/Rh2 + SM micelles and RUB/Rh2 micelles + RUB/SM micelles. Error bars indicated s.d. (n = 3). ***P < 0.001 (two-tailed Student’s t test)